pmc logo image
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds

Formats:

Br J Cancer. 1994 May; 69(5): 875–878.
PMCID: PMC1968917
The effects of low-level direct current therapy on a preclinical mammary carcinoma: tumour regression and systemic biochemical sequelae.
D. T. Griffin, N. J. Dodd, J. V. Moore, B. R. Pullan, and T. V. Taylor
Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.
Abstract
Low-level direct electric current has been shown to be capable of destroying tumour tissue. Using an early-passage subcutaneous murine mammary carcinoma, the relationships between the volume of tumour destruction, charge and polarity have been examined. The results revealed a direct correlation between charge passed and absolute volume regression when the intratumoral electrode was made either an anode or a cathode. Tumour destruction for a given charge was significantly greater following anodic than cathodic treatment. A direct correlation was also observed between the percentage volume of prompt treatment-induced regression and the in situ end point of tumour growth delay. During the course of these experiments, a highly reproducible toxic effect was discovered, which has not been previously reported for this modality. An anodic charge greater than 10.6 coulombs or a cathodic charge greater than 21.6 coulombs resulted in 100% mortality at 24-72 h, while lower charges had no influence on mortality. Quantitative assays of a number of blood parameters showed that mortality was associated with serum electrolyte imbalances and appeared to be the result of the metabolic load of tumour breakdown products. These effects are similar to the tumour lysis or surgical crush syndromes and should not constitute a significant problem in clinical practice, where the tumour mass to total body mass ratio will normally be much smaller.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (846K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Better OS. The crush syndrome revisited (1940-1990). Nephron. 1990;55(2):97–103. [PubMed]
  • David SL, Absolom DR, Smith CR, Gams J, Herbert MA. Effect of low level direct current on in vivo tumor growth in hamsters. Cancer Res. 1985 Nov;45(11 Pt 2):5625–5631. [PubMed]
  • HUMPHREY CE, SEAL EH. Biophysical approach toward tumor regression in mice. Science. 1959 Aug 14;130(3372):388–390. [PubMed]
  • Marino AA, Morris D, Arnold T. Electrical treatment of Lewis lung carcinoma in mice. J Surg Res. 1986 Aug;41(2):198–201. [PubMed]
  • Moore JV. The dynamics of tumor cords in an irradiated mouse mammary carcinoma with a large hypoxic cell component. Jpn J Cancer Res. 1988 Feb;79(2):236–243. [PubMed]
  • Moore JV, Dodd NJ, Wood B. Proton nuclear magnetic resonance imaging as a predictor of the outcome of photodynamic therapy of tumours. Br J Radiol. 1989 Sep;62(741):869–870. [PubMed]
  • Samuelsson L, Jönsson L. Electrolyte destruction of lung tissue. Electrochemical aspects. Acta Radiol Diagn (Stockh) 1980;21(6):711–714. [PubMed]
  • Samuelsson L, Olin T, Berg NO. Electrolytic destruction of lung tissue in the rabbit. Acta Radiol Diagn (Stockh) 1980;21(4):447–454. [PubMed]
  • Schauble MK, Habal MB, Gullick HD. Inhibition of experimental tumor growth in hamsters by small direct currents. Arch Pathol Lab Med. 1977 Jun;101(6):294–297. [PubMed]
  • van der Hoven B, Thunnissen PL, Sizoo W. Tumour lysis syndrome in haematological malignancies. Neth J Med. 1992 Feb;40(1-2):31–35. [PubMed]